Consumer-grade Wearable Devices in Arrhythmia Diagnostics for Clinicians: Where We Are and Where We Are Going

Overview

Journal J Interv Card Electrophysiol

Publisher Springer

Date 2025 Jan 25

PMID 39863724

Authors

Eric Rytkin

Irina Zotova

Rod Passman

Andrey Ardashev

Gregory Trachiotis

Igor Efimov

Bradley P Knight

Affiliations

Soon will be listed here.

Abstract

Atrial arrhythmias, including atrial fibrillation (AF), are a major contributor to cardiovascular morbidity and mortality. Early detection and effective management are critical to mitigating adverse outcomes such as stroke, heart failure, and overall mortality. Wearable devices have emerged as promising tools for monitoring, detecting, and managing atrial arrhythmias near-continuously. This comprehensive analysis explores these wearable technologies' current role and capabilities for clinicians' daily practice. Despite challenges related to data accuracy, privacy, patient compliance, and integration with healthcare systems, ongoing advancements hold significant promise for the future. Continued research and development are essential to fully realize the potential of wearables in improving clinical outcomes for patients with atrial arrhythmias.

References

Menke J, Luthje L, Kastrup A, Larsen J . Thromboembolism in atrial fibrillation. Am J Cardiol. 2010; 105(4):502-10. DOI: 10.1016/j.amjcard.2009.10.018. View

Benjamin E, Virani S, Callaway C, Chamberlain A, Chang A, Cheng S . Heart Disease and Stroke Statistics-2018 Update: A Report From the American Heart Association. Circulation. 2018; 137(12):e67-e492. DOI: 10.1161/CIR.0000000000000558. View

Noseworthy P, Kaufman E, Chen L, Chung M, Elkind M, Joglar J . Subclinical and Device-Detected Atrial Fibrillation: Pondering the Knowledge Gap: A Scientific Statement From the American Heart Association. Circulation. 2019; 140(25):e944-e963. PMC: 8438789. DOI: 10.1161/CIR.0000000000000740. View

McIntyre W, Benz A, Becher N, Healey J, Granger C, Rivard L . Direct Oral Anticoagulants for Stroke Prevention in Patients With Device-Detected Atrial Fibrillation: A Study-Level Meta-Analysis of the NOAH-AFNET 6 and ARTESiA Trials. Circulation. 2023; 149(13):981-988. DOI: 10.1161/CIRCULATIONAHA.123.067512. View

Kaplan R, Koehler J, Ziegler P, Sarkar S, Zweibel S, Passman R . Stroke Risk as a Function of Atrial Fibrillation Duration and CHADS-VASc Score. Circulation. 2019; 140(20):1639-1646. DOI: 10.1161/CIRCULATIONAHA.119.041303. View

Meschia J, Bushnell C, Boden-Albala B, Braun L, Bravata D, Chaturvedi S . Guidelines for the primary prevention of stroke: a statement for healthcare professionals from the American Heart Association/American Stroke Association. Stroke. 2014; 45(12):3754-832. PMC: 5020564. DOI: 10.1161/STR.0000000000000046. View

Hindricks G, Potpara T, Dagres N, Arbelo E, Bax J, Blomstrom-Lundqvist C . 2020 ESC Guidelines for the diagnosis and management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS): The Task Force for the diagnosis and management of atrial fibrillation of the.... Eur Heart J. 2020; 42(5):373-498. DOI: 10.1093/eurheartj/ehaa612. View

Lubitz S, Atlas S, Ashburner J, Lipsanopoulos A, Borowsky L, Guan W . Screening for Atrial Fibrillation in Older Adults at Primary Care Visits: VITAL-AF Randomized Controlled Trial. Circulation. 2022; 145(13):946-954. PMC: 8960369. DOI: 10.1161/CIRCULATIONAHA.121.057014. View

Jonas D, Kahwati L, Yun J, Middleton J, Coker-Schwimmer M, Asher G . Screening for Atrial Fibrillation With Electrocardiography: Evidence Report and Systematic Review for the US Preventive Services Task Force. JAMA. 2018; 320(5):485-498. DOI: 10.1001/jama.2018.4190. View

10.

Davidson K, Barry M, Mangione C, Cabana M, Caughey A, Davis E . Screening for Atrial Fibrillation: US Preventive Services Task Force Recommendation Statement. JAMA. 2022; 327(4):360-367. DOI: 10.1001/jama.2021.23732. View

11.

Benjamin E, Go A, Desvigne-Nickens P, Anderson C, Casadei B, Chen L . Research Priorities in Atrial Fibrillation Screening: A Report From a National Heart, Lung, and Blood Institute Virtual Workshop. Circulation. 2021; 143(4):372-388. PMC: 8776506. DOI: 10.1161/CIRCULATIONAHA.120.047633. View

12.

Joglar J, Chung M, Armbruster A, Benjamin E, Chyou J, Cronin E . 2023 ACC/AHA/ACCP/HRS Guideline for the Diagnosis and Management of Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines. Circulation. 2023; 149(1):e1-e156. PMC: 11095842. DOI: 10.1161/CIR.0000000000001193. View

13.

Ryden L, Asinger R, Cannom D, Crijns H, Frye R, Halperin J . ACC/AHA/ESC guidelines for the management of patients with atrial fibrillation: executive summary. A Report of the American College of Cardiology/ American Heart Association Task Force on Practice Guidelines and the European Society of Cardiology.... J Am Coll Cardiol. 2001; 38(4):1231-66. DOI: 10.1016/s0735-1097(01)01587-x. View

14.

January C, Samuel Wann L, Calkins H, Chen L, Cigarroa J, Cleveland Jr J . 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation: A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines and the.... J Am Coll Cardiol. 2019; 74(1):104-132. DOI: 10.1016/j.jacc.2019.01.011. View

15.

Voight J, Akkaya M, Somasundaram P, Karim R, Valliani S, Kwon Y . Risk of new-onset atrial fibrillation and stroke after radiofrequency ablation of isolated, typical atrial flutter. Heart Rhythm. 2014; 11(11):1884-9. DOI: 10.1016/j.hrthm.2014.06.038. View

16.

Nedios S, Sommer P, Dagres N, Kosiuk J, Arya A, Richter S . Long-term follow-up after atrial fibrillation ablation in patients with impaired left ventricular systolic function: the importance of rhythm and rate control. Heart Rhythm. 2013; 11(3):344-51. DOI: 10.1016/j.hrthm.2013.12.031. View

17.

Bernstein R, Kamel H, Granger C, Piccini J, Sethi P, Katz J . Effect of Long-term Continuous Cardiac Monitoring vs Usual Care on Detection of Atrial Fibrillation in Patients With Stroke Attributed to Large- or Small-Vessel Disease: The STROKE-AF Randomized Clinical Trial. JAMA. 2021; 325(21):2169-2177. PMC: 8170544. DOI: 10.1001/jama.2021.6470. View

18.

Buck B, Hill M, Quinn F, Butcher K, Menon B, Gulamhusein S . Effect of Implantable vs Prolonged External Electrocardiographic Monitoring on Atrial Fibrillation Detection in Patients With Ischemic Stroke: The PER DIEM Randomized Clinical Trial. JAMA. 2021; 325(21):2160-2168. PMC: 8170545. DOI: 10.1001/jama.2021.6128. View

19.

Gladstone D, Spring M, Dorian P, Panzov V, Thorpe K, Hall J . Atrial fibrillation in patients with cryptogenic stroke. N Engl J Med. 2014; 370(26):2467-77. DOI: 10.1056/NEJMoa1311376. View

20.

Rizas K, Freyer L, Sappler N, von Stulpnagel L, Spielbichler P, Krasniqi A . Smartphone-based screening for atrial fibrillation: a pragmatic randomized clinical trial. Nat Med. 2022; 28(9):1823-1830. DOI: 10.1038/s41591-022-01979-w. View